Histological subtype matters: a multicenter study reveals distinct prognosis between pure and mixed small cell neuroendocrine carcinoma of the esophagus

Background Esophageal neuroendocrine carcinoma (NEC) is a rare and highly aggressive malignancy characterized by rapid progression, early metastasis, and poor survival outcomes. However, the prognostic significance of histological subtype, particularly pure small cell NEC (pSCNEC) and mixed small cell NEC (mSCNEC), remains unclear. Methods In this retrospective multicenter cohort study, we analyzed 118 patients with esophageal NEC as the primary cohort and included an independent external validation cohort of 58 patients. Patients were classified as pSCNEC or mSCNEC according to histological composition. Clinicopathological characteristics, immunohistochemical profiles, treatment modalities, treatment failure patterns (recurrence or progression), and survival outcomes were systematically compared. Univariate and multivariate Cox regression analyses were performed to identify independent prognostic factors, and a prognostic nomogram was constructed. Results During median observed follow-up durations of 24.0 months in the primary cohort and 25.0 months in the external validation cohort, 118 and 58 death events were observed, respectively. mSCNEC was associated with longer tumor length and a higher incidence of lymph node metastasis, whereas hematogenous involvement as a treatment failure pattern occurred more frequently in pSCNEC. Multivariate analysis identified two-stage classification (HR = 3.172, 95% CI: 1.617-6.223, P = 0.001) and histological subtype (mSCNEC vs. pSCNEC: HR = 0.647, 95% CI: 0.428-0.977, P = 0.039) as independent predictors of overall survival. Patients with pSCNEC exhibited significantly worse survival than those with mSCNEC in both the primary cohort [median survival: 18.5 months (95% CI: 15.0–26.0) vs. 36.0 months (95% CI: 24.0–53.0)] and the external validation cohort [median survival: 21 months (95% CI: 14.0–28.0) vs. 37 months (95% CI: 14.0–72.0)]. Exploratory analyses in the subset with available immunohistochemical data suggested an association between NSE positivity and poorer overall survival. Conclusions Histological subtype was independently associated with overall survival in the primary cohort, with supportive evidence from the smaller external cohort. Its potential contribution to risk stratification warrants further evaluation in larger independent cohorts.

Authors

Institutions

Publication Details

Journal
Frontiers in Endocrinology
Published
2026-11-19
DOI
https://doi.org/10.3389/fendo.2026.1970048
Primary Topic
Neuroendocrine Tumor Research Advances
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Histological subtype matters: a multicenter study reveals distinct prognosis between pure and mixed small cell neuroendocrine carcinoma of the esophagus

Hidetaka Uramoto, Xuemin Yao, Fuhui Zhang, Jia Han et al.
Frontiers in Endocrinology
Neuroendocrine Tumor Research Advances
article

Histological subtype matters: a multicenter study reveals distinct prognosis between pure and mixed small cell neuroendocrine carcinoma of the esophagus

Hidetaka Uramoto, Xuemin Yao, Fuhui Zhang, Jia Han, Wenpeng Jiao, Danqing Li, Chang Liu, Wenjing Jiao, Yao Liu, Sohsuke Yamada
article en

Abstract

Background Esophageal neuroendocrine carcinoma (NEC) is a rare and highly aggressive malignancy characterized by rapid progression, early metastasis, and poor survival outcomes. However, the prognostic significance of histological subtype, particularly pure small cell NEC (pSCNEC) and mixed small cell NEC (mSCNEC), remains unclear. Methods In this retrospective multicenter cohort study, we analyzed 118 patients with esophageal NEC as the primary cohort and included an independent external validation cohort of 58 patients. Patients were classified as pSCNEC or mSCNEC according to histological composition. Clinicopathological characteristics, immunohistochemical profiles, treatment modalities, treatment failure patterns (recurrence or progression), and survival outcomes were systematically compared. Univariate and multivariate Cox regression analyses were performed to identify independent prognostic factors, and a prognostic nomogram was constructed. Results During median observed follow-up durations of 24.0 months in the primary cohort and 25.0 months in the external validation cohort, 118 and 58 death events were observed, respectively. mSCNEC was associated with longer tumor length and a higher incidence of lymph node metastasis, whereas hematogenous involvement as a treatment failure pattern occurred more frequently in pSCNEC. Multivariate analysis identified two-stage classification (HR = 3.172, 95% CI: 1.617-6.223, P = 0.001) and histological subtype (mSCNEC vs. pSCNEC: HR = 0.647, 95% CI: 0.428-0.977, P = 0.039) as independent predictors of overall survival. Patients with pSCNEC exhibited significantly worse survival than those with mSCNEC in both the primary cohort [median survival: 18.5 months (95% CI: 15.0–26.0) vs. 36.0 months (95% CI: 24.0–53.0)] and the external validation cohort [median survival: 21 months (95% CI: 14.0–28.0) vs. 37 months (95% CI: 14.0–72.0)]. Exploratory analyses in the subset with available immunohistochemical data suggested an association between NSE positivity and poorer overall survival. Conclusions Histological subtype was independently associated with overall survival in the primary cohort, with supportive evidence from the smaller external cohort. Its potential contribution to risk stratification warrants further evaluation in larger independent cohorts.

Frontiers in EndocrinologyVol. 17
Hebei Medical University (CN), North China University of Science and Technology (CN), Kanazawa Medical University (JP), University of Occupational and Environmental Health Japan (JP), Tangshan People's Hospital (CN), Kanazawa University Hospital (JP), Fourth Hospital of Hebei Medical University (CN), North China University of Science and Technology Affiliated Hospital (CN), Xingtai People's Hospital (CN), Kanazawa Medical University Hospital (JP)
Neuroendocrine Tumor Research Advances
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon